Benzene is an established human carcinogen associated with acute myeloid leukemia. Exposure occurs in petroleum refining, chemical manufacturing, painting, and printing, and historically in products containing benzene as a solvent or contaminant.
Dose-response relationships are documented for AML.
Alternative Names:
Benzene Litigation, Benzene Claims
Why it Matters?
General causation is established for acute myeloid leukemia but contested for other hematologic conditions, which makes the specific diagnosis a threshold issue rather than a detail. Dose is the second battleground, since documented exposure thresholds exist and a claimant whose reconstructed cumulative exposure falls well below them faces a specific causation problem. Product benzene content and industrial hygiene data drive that analysis.
Frequently Confused with
Related terms
Frequently asked questions
Which conditions have established causation?
What drives the specific causation analysis?
